Open | $4.710 |
Close | $4.710 |
Volume / Avg. | 0 / 885.092K |
Day Range | 4.520 - 4.740 |
52 Wk Range | 1.630 - 5.700 |
Market Cap | $650.678M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 42 |
Short Interest | % |
Days to Cover | 3.48 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Savara (NASDAQ: SVRA) through any online brokerage.
Other companies in Savara’s space includes: Cogent Biosciences (NASDAQ:COGT), Fusion Pharmaceuticals (NASDAQ:FUSN), Fate Therapeutics (NASDAQ:FATE), Pharming (NASDAQ:PHAR) and AnaptysBio (NASDAQ:ANAB).
The latest price target for Savara (NASDAQ: SVRA) was reported by HC Wainwright & Co. on Monday, March 11, 2024. The analyst firm set a price target for 6.00 expecting SVRA to rise to within 12 months (a possible 27.39% upside). 9 analyst firms have reported ratings in the last year.
The stock price for Savara (NASDAQ: SVRA) is $4.71 last updated March 18, 2024 at 4:00 PM EDT.
There are no upcoming dividends for Savara.
Savara’s Q1 earnings are confirmed for Monday, May 13, 2024.
There is no upcoming split for Savara.
Savara is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.